# Dermatopharmacokinetic Trial of LEO 90100 Foam

> **NCT03476746** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 58 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LEO 90100 foam
- **DRUG:** Dovobet® ointment

## Key facts

- **NCT ID:** NCT03476746
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03476746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03476746, "Dermatopharmacokinetic Trial of LEO 90100 Foam". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03476746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*